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Chlorination by-products in drinking water
come from the reaction of chlorine with
organic material in the water. This reaction
occurs naturally or originates from municipal,
agricultural, and industrial wastes. Trihalo-
methanes (THMs) such as chloroform, bromo-
form, bromodichloromethane (BDCM), and
chlorodibromomethane are the most prevalent
class of disinfection by-products (DBPs)
found in treated water. From the toxicologic
literature, chloroform appears to affect fetal
development (Geveker Graves et al. 2001), by
mechanisms that have not yet been elucidated.
In the last decade, a number of epidemiologic
studies have been carried out to determine the
effect of DBPs on adverse pregnancy out-
comes (Bove et al. 2002). Two recent reviews
propose that the weight of the evidence,
although moderate and not fully conclusive, is
in favor of an association between DBPs and
fetal growth restriction (Bove et al. 2002;
Geveker Graves et al. 2001). Most of the pre-
vious studies were based on information from
birth records, and despite the fact that the
number of records included was usually large,
the information that was available on other
risk factors for fetal growth, or on other per-
sonal variables inﬂuencing exposure to DBPs,
was often limited.
The primary enzyme involved in the
metabolism of low doses of chloroform is
CYP2E1 (Meek et al. 2002). My group has
previously shown that a polymorphism in the
CYP2E1 gene can modify the effect of water
contaminants (Infante-Rivard et al. 2002a).
Another enzyme, 5,10-methylenetetrahydro-
folate reductase (MTHFR), together with
folic acid, is involved in the remethylation of
homocysteine to methionine, as well as in the
methylation of DNA, proteins, and phospho-
lipids (Botto and Yang 2000). Alston (1991)
reported that vitamin B12-dependent methio-
nine biosynthesis could be inhibited by
chloroform. Common polymorphisms in the
MTHFR gene have been identified (Botto
and Yang 2000). To my knowledge, no study
has considered the role of genetic polymor-
phisms on the relationship between DBPs
and fetal growth.
My group carried out a study on genetic
and metabolic risk factors for intrauterine
growth restriction (IUGR) (Infante-Rivard
et al. 2002b, 2003a, 2003b). In the course of
the study, we also collected personal and
environmental information to analyze the
association between chemical water contami-
nants and fetal growth.
Materials and Methods
Study subjects. Details on study subjects have
been reported elsewhere (Infante-Rivard et al.
2002b). Briefly, cases were newborns whose
birth weight was below the 10th percentile for
gestational age and sex, based on Canadian
standards (Arbuckle et al. 1993). All cases seen
at the largest university-based mother–child
center in Montréal between May 1998 and
June 2000 who were born singleton, alive after
the 24th week of gestation, and without severe
congenital anomalies were eligible for the
study. During that period, 505 newborns met
the eligibility criteria, and 493 were included
in the study (97.6%). Controls were born at
the same hospital and met the same eligibility
criteria, except that their birth weight was at or
above the 10th percentile. They were matched
to cases for gestational week, sex, and race
(white, black, Hispanic/Amerindian, and
Asian) and usually born within 1 week of the
matched case subject. Of those identified,
480 controls were invited to participate, and
472 accepted (98.3%). The project was
approved by the hospital ethics committee. An
informed consent was signed by the mother to
collect cord and maternal blood.
Interview. A face-to-face interview with all
mothers of cases and controls was carried out
in French or English at the hospital, generally
within 2 days of delivery. It included questions
about demographic factors, complications of
pregnancy, maternal chronic diseases, obstetric
history, and smoking. The medical record was
used for variables such as height and weight
and to conﬁrm pregnancy diseases. To deter-
mine exposure to water contaminants for each
pregnancy trimester until delivery, we collected
the following information: maternal residential
history, source of drinking water (community,
private well, bottled), use and type of domestic
water ﬁlter, average number of glasses of water
per day at home or elsewhere (including those
with reconstituted frozen fruit juices), usual
way of consuming tap water (directly from tap,
after refrigeration), average number of showers
per week, and usual duration of showers.
Exposure ascertainment. For the study
period, exposure to THMs from drinking water
according to place of residence was obtained
from regulatory data collected by municipali-
ties and the Ministry of Environment. There
were 189 distribution systems involved;
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There are still many uncertainties regarding the risk of adverse pregnancy outcomes associated with
exposure to drinking water disinfection by-products. In Montréal, Québec, Canada, we carried out
a hospital-based case–control study including 493 cases of intrauterine growth restriction deﬁned as
birth weight below the 10th percentile for gestational age and sex, according to Canadian stan-
dards. Controls were babies (n = 472) delivered at the same hospital whose birth weight was at or
above the 10th percentile, matched for gestational age, race, and sex. Exposure to total and speciﬁc
trihalomethanes was measured using regulatory data collected by municipalities and the provincial
Ministry of Environment. Residential history, water drinking, and shower habits during pregnancy,
as well as known risk factors for intrauterine growth restriction, were measured with a face-to-face
interview with all mothers. Mothers and newborns were characterized for two genetic polymor-
phisms, one in the CYP2E1 gene (G1259C), and another in the 5,10-methylenetetrahydrofolate
reductase (MTHFR) gene (C677T). Exposure to speciﬁc and total trihalomethanes from drinking
water, determined for 458 cases and 426 controls, did not result in an increased risk of intrauterine
growth restriction. However, signiﬁcant effect modiﬁcation was observed between newborns with
and without the CYP2E1 variant; among newborns with the variant, the adjusted odds ratio for
intrauterine growth restriction associated with exposure to average total trihalomethanes above the
90th percentile (corresponding to 29.4 µg/L) was 13.20 (95% conﬁdence interval, 1.19–146.72).
These ﬁndings suggest that exposure to trihalomethanes at the highest levels can affect fetal growth
but only in genetically susceptible newborns. Key words: CYP2E1 gene, disinfection by-products,
drinking water, gene polymorphism, gene–environment interaction, intrauterine growth restric-
tion, low birth weight, MTHFR gene, trihalomethanes. Environ Health Perspect 112:1213–1216
(2004). doi:10.1289/ehp.7003 available via http://dx.doi.org/ [Online 26 May 2004]although for most systems there were multiple
measurements on the same date, I was only
provided with average measures. Of the
965 women in the study, 10 lived in other
Canadian provinces, 37 lived in other coun-
tries, and there was no address for 2 others,
leaving 916 study women reporting addresses
in the province. Overall, THM information
was available for 884 (91.6%) of the study
women (458 cases and 426 controls).
Exposure from drinking water. Estimates of
exposure levels to total and speciﬁc THMs from
drinking water were tabulated ﬁrst as average
level at the tap (from treatment plant data) over
the pregnancy period [(sum of concentration i ×
duration in days at level i based on residence) ÷
(total number of pregnancy days)]; this measure
was then categorized at the 90th percentile of
the distribution for cases and controls. Another
index was the cumulative level over the preg-
nancy period (sum of concentration i × duration
in days at level i); it was also categorized at the
90th percentile of the distribution. When the
source of drinking water was exclusively well
water or bottled water, the exposure levels for
drinking water were set at zero. Finally, the esti-
mated average level of THMs at the tap from
the municipal distribution system was multi-
plied by the number of glasses of tap water per
day averaged over pregnancy. Another version of
this index included applying an arbitrary weight
of 0.9 to the average number of tap water glasses
if a ﬁlter was used or if the water was refrigerated
before consumption.
Exposure from showering. Exposure to
THMs from showering was set to zero for res-
idences using exclusively well water, others
were assigned their network level. An index of
exposure to THMs from showering was
defined as frequency of showers per week
(times duration) multiplied by the average
levels of exposure to THMs at the tap from
the distributing network.
Genotyping. Polymerase chain reaction
(PCR) allele-speciﬁc oligonucleotide hybridiza-
tion assays have been used to genotype the
polymorphism G1259C (a G-to-C substitution
at position 1259 in the promoter) that deﬁnes
the allele CYP2E1*5 (Infante-Rivard et al.
2002a) as well as the MTHFR C677T poly-
morphism (Infante-Rivard et al. 2002b).
Statistical analysis. Out of 493 cases and
472 controls, 451 were matched for gestational
week, sex, and race. Because the matching
involved only categorical factors, odds ratios
(ORs) and 95% confidence intervals (CIs)
were estimated using unconditional logistic
regression analysis, allowing all study subjects
to be included. I included race, sex, and gesta-
tional age as confounding variables in all analy-
ses, as well as the following risk factors known
to be associated with IUGR: weight gain dur-
ing pregnancy, prepregnancy body mass index
(BMI), parity, history of preeclampsia, prior
history of IUGR, primiparity, and smoking
during pregnancy. I also tested for gene–
environment interactions, that is, whether the
effect of water contaminants (total THMs and
chloroform in tap water) was modiﬁed by new-
born and maternal genetic variants (one or two
variant alleles vs. none), using a heterogeneity
chi-square test (Hills and De Stavola 2002).
Results
Table 1 provides some background maternal
characteristics for cases and controls. As
expected, case mothers had gained less weight
during pregnancy and had a lower BMI before
pregnancy. In addition, they were more likely
to be older, to have smoked during the third
trimester of pregnancy, to be primiparous, to
have preeclampsia, and to report a previous
pregnancy with IUGR.
Table 2 shows the distribution of exposure
variables such as different THMs as well as
showering and drinking-water habits. The only
notable difference between cases and controls
was the use of domestic water ﬁlters, which was
higher among controls.
Table 3 shows the results for exposure to
specific and total THMs in drinking water
using the 90th percentile cutoff for average
level of exposure. No increased risk was
observed for any of the speciﬁc THMs or for
total THMs. All reported ORs were fully
adjusted. Using a cutoff at the 95th percentile
(instead of the 90th) for average level of 
exposure, I estimated an OR of 1.17 (95%
CI, 0.60–2.29) for chloroform and of 1.26
(95% CI, 0.65–2.45) for total THMs. I also
estimated ORs for cumulative exposure to
specific and total THMs in drinking water
and found that results were very similar to
those for average exposure (data not shown).
Using the other indices for drinking water
and the index for showering, I observed no
increased risks (data not shown).
Table 4 shows the adjusted ORs for expo-
sure to average levels of chloroform and total
THMs from drinking water (contrasting the
group above the 90th percentile with the group
at or below the 90th), according to whether
the newborn or the mother carried one or two
variant alleles, as opposed to none. The risk of
IUGR associated with exposure to total
THMs was different between newborn carriers
and noncarriers of the CYP2E1 variant. An
increased risk was also observed among the
newborn carriers for exposure to chloroform,
as well as among mother carriers for both expo-
sures (chloroform and total THMs), but the
risks were not statistically different across the
gene strata. I also observed statistical hetero-
geneity in the risk of IUGR between newborns
carriers and noncarriers of the CYP2E1 variant
for exposure to average levels of chloroform
and total THMs measured as numerical vari-
ables (data not shown). No effect modiﬁcation
was observed when contrasting carriers and
noncarriers of the T allele in the MTHFR
Children’s Health | Infante-Rivard
1214 VOLUME 112 | NUMBER 11 | August 2004 • Environmental Health Perspectives
Table 1. Distribution of maternal characteristics between cases (n = 493) and controls (n = 472).
Characteristic Cases Controls
Race [no. (%)]
White 330 (66.9) 333 (70.5)
Black 117 (23.7) 110 (23.3)
Asian 24 (4.8) 13 (2.7)
Hispanic/Amerindian 22 (4.4) 16 (3.4)
Age ≥ 36 years [no. (%)] 86 (17.4) 70 (14.8)
Schooling ≤ 12 years [no. (%)] 108 (21.9) 96 (20.3)
Prepregnancy BMI (mean ± SD) 22.8 ± 4.3 23.2 ± 5.2
Weight gain during pregnancy, kg (mean ± SD) 12.7 ± 5.5 14.4 ± 5.6
Primiparous [no. (%)] 321 (65.2) 234 (49.6)
Preeclampsia [no. (%)] 69 (14.0) 12 (2.5)
Previous IUGR among parous [no. (%)] 66 (38.4) 23 (9.7)
Any cigarette smoking in 3rd trimester [no. (%)] 112 (22.7) 72 (15.7)
Table 2. Distribution of exposure variables between cases and controls.
Variable Cases Controls
THM concentration (µg/L) at the tap (mean ± SD)
Chloroform 11.84 ± 18.19 11.58 ± 16.31
Bromoform 0.42 ± 0.62 0.36 ± 0.65
BDCM 4.34 ± 2.94 4.24 ± 3.42
Chlorodibromomethane 2.21 ± 1.95 2.08 ± 2.30
Total THM 18.74 ± 19.76 18.26 ± 18.89
Other exposure characteristics
Drinking bottled water (%) 21.9 26.4
Private well (%) 0.66 0.95
Use of domestic water ﬁlter at tap (%) 14.7 9.9
Glasses of water/daya (mean ± SD) 6.8 ± 4.7 6.7 ± 4.2
No. of weekly showers (mean ± SD) 6.8 ± 3.9 6.9 ± 3.8
Duration of showers, min (mean ± SD) 12.6 ± 8.3 13.1 ± 7.3
aIncludes water mixed with frozen juices.C677T gene. No signiﬁcant effect modiﬁcation
was observed between newborn or maternal
carriers and noncarriers of either polymorphism
when exposure was defined with the other
indices for drinking water or for showering.
Discussion
My results for the association between expo-
sure to water contaminants were largely nega-
tive, whether average or cumulative levels
from drinking water at the tap were used or
when I also accounted for drinking water and
showering habits. There were some indications
that, with increased genetic susceptibility, espe-
cially in the newborn, measured by the pres-
ence of a variant in the CYP2E1 gene, exposure
to total THMs was associated with substantial
risk. I know of no similar results.
The results from previous studies are mixed
with respect to IUGR (often referred to as small
for gestational age): Four studies reported associ-
ations (Bove et al. 1995; Gallagher et al. 1998;
Kramer et al. 1992; Wright et al. 2003), and
ﬁve did not (Dodds et al. 1999; Jaakkola et al.
2001; Kallen and Robert 2000; Savitz et al.
1995; Yang et al. 2000). In the present study,
selection bias was unlikely. Exposure assessment
at the personal level was more detailed than in
most previous studies because I accounted for
the use of bottled water as drinking water,
the drinking habits, and the showering habits
(although not the bathing habits). A substantial
proportion of women were drinking only bot-
tled water, which inﬂuenced the levels of expo-
sure to THMs reported in the study. Despite
these positive features, misclassiﬁcation of expo-
sure to water contaminants was most certainly
present; in particular, better measures could be
achieved if assigned levels were based on speciﬁc
locations within the distribution systems when
multiple locations within the system were sam-
pled. Another advantage of this study, com-
pared with many of the previous studies using
birth records, was the extensive control for con-
founding; gestational age, child’s sex, race,
maternal smoking, primiparity, weight gain
during pregnancy, BMI, previous IUGR, and
pregnancy hypertension are all known risk fac-
tors for IUGR for which I was able to adjust.
Despite the absence of association between
exposure to THMs and IUGR, the adverse
effects of exposure of THMs were uncovered
when taking into account genetic susceptibil-
ity. The study included subjects from many
racial backgrounds; confounding by ethnicity,
known as population stratification, can bias
the results of case–control studies with genetic
risk factors. However, I adjusted for race in all
analyses. Other confounders for IUGR were
measured and controlled for in the analysis.
The mechanism by which exposure to
THMs affects fetal growth is not known;
among humans, almost all studies have been
epidemiologic, and therefore other types of
studies addressing mechanisms are not avail-
able. A recent toxicologic study hypothesized
that BDCM could disrupt the synthesis and/or
secretion of placental syncytiotrophoblast-
derived chorionic gonadotropin (Chen et al.
2003). The authors tested whether BDCM
targets trophoblasts by examining the effect of
BDCM on chorionic gonadotropin secretion
by primary cultures of human trophoblasts.
The results showed that BDCM reduced the
secretion of immunoreactive and bioactive
chorionic gonadotropin, and thus the com-
ponent appears to target human placental
trophoblasts. Trophoblasts are the sole source
of chorionic gonadotropin during normal
human pregnancy; thus, a decrease in the
amount of this bioactive hormone could
have adverse effects on pregnancy outcome.
However, much more work is still needed
to elucidate the possible effects on human
fetal growth.
A few years ago, Chen et al. (1996) were
the ﬁrst to suggest that carriers of the common
MTHFR C677T polymorphism could be at
higher risk for the effects of chloroform in
drinking water. MTHFR is involved in the
metabolism of methionine and homocysteine
through a mechanism that is vitamin B12
dependent; as suggested by Alston (1991),
the latter could be inhibited by chloroform.
Among carriers of the T allele, in particular the
homozygotes, the transformation of homo-
cysteine to methionine is less efﬁcient and pos-
sibly the exposure to chloroform could inhibit
this transformation even more. In this study, I
found no indication that MTHFR C677T will
modify the effect of exposure to chloroform. It
is likely that this is not a promising hypothesis
after all, at least for fetal growth.
The tested variant in CYP2E1 is in the
regulatory region and is associated with an
increased transcriptional activity (Hayashi
et al. 1991). The carriers would be expected
to have an increased metabolism of THMs
resulting in the production of activated
metabolites. Our results are coherent with
this hypothesis. This indication for gene–
environment interaction should lead to more
similar investigations because it is very
unlikely that only one polymorphic gene is
involved in the metabolism of THMs.
In conclusion, in the present study I was
unable to show effects of exposure to THMs
from DBPs on the risk of IUGR. However,
among newborn carriers of a CYP2E1 gene
variant, important effects were observed.
These results will need confirmation. They
also suggest that accounting for genetic sus-
ceptibility is a sensible way to study the effects
of environmental exposures when there is
information on the candidate genes involved
in the metabolism of these agents.
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Table 4. Adjusteda ORs (95% CIs) for exposure to THMs (chloroform and total THMs) in drinking water
measured as average level at the tap, according to newborn and maternal polymorphisms in the CYP2E1
and MTHFR genes.
OR (95% CI)b
Gene Cases (n) Controls (n) Chloroform Total THMs
Newborns
CYP2E1*5 (G1259C)
Wild type 385 375 0.99 (0.57–1.74) 0.82 (0.47–1.45)
1 or 2 variant alleles 45 37 5.62 (0.82–38.39) 13.20 (1.19–146.72)*
MTHFR C677T
Wild type 239 212 1.78 (0.82–3.87) 1.63 (0.72–3.71)
1 or 2 variant alleles 195 204 0.83 (0.38–1.54) 0.76 (0.38–1.54)
Mothers
CYP2E1*5 G1259C
Wild type 395 380 0.88 (0.50–1.54) 0.83 (0.48–1.44)
1 or 2 variant alleles 57 39 4.40 (0.73–26.42) 6.54 (0.59–71.45)
MTHFR C677T
Wild type 244 214 1.00 (0.46–2.18) 0.98 (0.46–2.10)
1 or 2 variant alleles 212 206 1.12 (0.56–2.32) 0.94 (0.47–1.89)
aAdjusted for gestational age, sex, race, mother’s weight gain during pregnancy, prepregnancy BMI, smoking during the
third trimester, primiparity, preeclampsia in the current pregnancy, and previous IUGR. bFor exposure deﬁned as average
level (> 90th percentile vs. ≤ 90th percentile). *Chi-square (1 degree of freedom) for effect modiﬁcation = 4.87; p = 0.027.
Table 3. Adjusteda ORs (95% CIs) for IUGR in relation to exposure to speciﬁc and total THMs in drinking
water measured as average levels at the tap.
Exposure index Value at cutoff (µg/L) OR (95% CI)
Average level ( > 90th percentile vs. ≤ 90th percentile)
Chloroform 23.7 1.06 (0.63–1.79)
Bromoform 1.22 2.44 (0.19–31.10)
BDCM 6.3 0.84 (0.50–1.43)
Chlorodibromomethane 3.9 0.62 (0.27–1.44)
Total THM 29.4 0.97 (0.57–1.62)
aAdjusted for gestational age, sex, race, mother’s weight gain during pregnancy, prepregnancy BMI, smoking during the
third trimester, primiparity, preeclampsia in the current pregnancy, and previous IUGR.REFERENCES
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